Expertise in
4
conditions
Expertise in
4
conditions
Hackensack University Medical Center
30 Prospect Avenue, Pediatric Blood And Marrow Transplant, 
Hackensack, NJ 

Overview

Burton Appel is a Pediatric Hematologist Oncology provider in Hackensack, New Jersey. Dr. Appel is highly rated in 4 conditions, according to our data. His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 22 peer reviewed articles and participating in 39 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Chicago Pritzker School Of Medicine

Specialties

Pediatric Hematology Oncology

Licenses

Pediatric Hematology-Oncology in NJ

Board Certifications

American Board Of Pediatrics
American Board Of Pediatrics

Fellowships

University of Chicago Comer Childrens Hospital

Languages Spoken

English
Hebrew

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Hackensack University Medical Center
30 Prospect Avenue, Pediatric Blood And Marrow Transplant, Hackensack, NJ 7601.
Other Locations
Children's Cancer Institute
61 Davis Avenue, Suite 1, Neptune, NJ 7753.

Additional Areas of Focus

Dr. Appel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


39 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 36 Less Clinical Trials
Similar Doctors
Expertise in
19
conditions
Pediatric Hematology Oncology
Expertise in
19
conditions
Pediatric Hematology Oncology
1275 York Ave, 
New York, NY 
 (9.8 miles away)
Languages Spoken:
English

Farid Boulad is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Boulad is highly rated in 19 conditions, according to our data. His top areas of expertise are Congenital Aplastic Anemia, Fanconi Anemia, Aplastic Anemia, Anemia, and Bone Marrow Transplant.

Jeffrey M. Lipton
Expertise in
7
conditions
Pediatric Hematology Oncology
Expertise in
7
conditions
Pediatric Hematology Oncology

Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant

269-01 76th Avenue, Suite 255, 
New Hyde Park, NY 
 (20.3 miles away)
Languages Spoken:
English

Jeffrey Lipton is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Lipton is highly rated in 7 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Transient Erythroblastopenia of Childhood, Aplastic Anemia, and Bone Marrow Transplant.

Expertise in
5
conditions
Pediatric Hematology Oncology
Expertise in
5
conditions
Pediatric Hematology Oncology
525 E 68th St # P-695, 
New York, NY 
 (9.8 miles away)
Languages Spoken:
English

James Bussel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Bussel is highly rated in 5 conditions, according to our data. His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Anemia, Hemolysis, and Splenectomy.

Frequently Asked Questions about Dr. Burton E. Appel

How do I make an appointment with Dr. Burton E. Appel?

You can book an appointment with Dr. Burton E. Appel by calling their office at 551-996-5437. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Burton E. Appel a top-rated expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Burton E. Appel is classified as an Distinguished expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Burton E. Appel specialize in?

While Dr. Burton E. Appel is a Pediatric Hematology Oncology, they have specific expertise in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, and Acute Lymphoblastic Leukemia (ALL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.

Does Dr. Burton E. Appel participate in research or clinical trials?

Yes. Dr. Burton E. Appel has published 22 articles and abstracts on conditions like Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). You can view a list of Dr. Burton E. Appel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Burton E. Appel accept my insurance?

Dr. Burton E. Appel accepts most major insurance plans, including Cigna and Horizon Healthcare. We recommend calling the office directly at 551-996-5437 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Appel's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile